Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phei Er Saw

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Macromolecular Rapid Communications|May 19, 2011
Efficient Liposomal Nanocarrier-mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell-Penetrating Peptide as a Packaging and Intracellular Delivery AgentPhei Er Saw, Young Tag Ko, Sangyong Jon
Chemmedchem|March 9, 2022
Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery SystemPhei Er Saw, Guo-Hui Cui, Xiaoding Xu
Journal of the National Cancer Center|August 15, 2025
Silver Jubilee of HER2 targeting: a clinical success in breast cancerJianli Zhao, Ziyue Zhou, Phei Er Saw, et al.
International Journal of Nanomedicine|May 16, 2022
Fully Natural Lecithin Encapsulated Nano-Resveratrol for Anti-Cancer TherapyMeiyi Liang, Mingyan Guo, Phei Er Saw, et al.
Trends in Immunology|May 27, 2022
Turning cold tumors hot: from molecular mechanisms to clinical applicationsJiahui Zhang, Di Huang, Phei Er Saw, et al.
Micromachines|January 21, 2022
Transforming Tea Catechins into Potent Anticancer Compound: Analysis of Three Boronated-PEG Delivery SystemMingyan Guo, Lukas Marek, Yixia Liang, et al.
Accounts of Chemical Research|August 18, 2021
Biomedical Applications of a Novel Class of High-Affinity PeptidesPhei Er Saw, Xiaoding Xu, Sunghyun Kim, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 5, 2016
A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectinPhei Er Saw, Jinho Park, Sangyong Jon, et al.
Science China. Life Sciences|September 15, 2020
Non-coding RNAs: the new central dogma of cancer biologyPhei Er Saw, Xiaoding Xu, Jianing Chen, et al.
Cell Stem Cell|June 26, 2024
Cancer stem cell mimicry for immune evasion and therapeutic resistancePhei Er Saw, Qiang Liu, Ping-Pui Wong, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Macromolecular Rapid Communications|May 19, 2011
Efficient Liposomal Nanocarrier-mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell-Penetrating Peptide as a Packaging and Intracellular Delivery AgentPhei Er Saw, Young Tag Ko, Sangyong Jon
Chemmedchem|March 9, 2022
Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery SystemPhei Er Saw, Guo-Hui Cui, Xiaoding Xu
Journal of the National Cancer Center|August 15, 2025
Silver Jubilee of HER2 targeting: a clinical success in breast cancerJianli Zhao, Ziyue Zhou, Phei Er Saw, et al.
International Journal of Nanomedicine|May 16, 2022
Fully Natural Lecithin Encapsulated Nano-Resveratrol for Anti-Cancer TherapyMeiyi Liang, Mingyan Guo, Phei Er Saw, et al.
Trends in Immunology|May 27, 2022
Turning cold tumors hot: from molecular mechanisms to clinical applicationsJiahui Zhang, Di Huang, Phei Er Saw, et al.
Micromachines|January 21, 2022
Transforming Tea Catechins into Potent Anticancer Compound: Analysis of Three Boronated-PEG Delivery SystemMingyan Guo, Lukas Marek, Yixia Liang, et al.
Accounts of Chemical Research|August 18, 2021
Biomedical Applications of a Novel Class of High-Affinity PeptidesPhei Er Saw, Xiaoding Xu, Sunghyun Kim, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 5, 2016
A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectinPhei Er Saw, Jinho Park, Sangyong Jon, et al.
Science China. Life Sciences|September 15, 2020
Non-coding RNAs: the new central dogma of cancer biologyPhei Er Saw, Xiaoding Xu, Jianing Chen, et al.
Cell Stem Cell|June 26, 2024
Cancer stem cell mimicry for immune evasion and therapeutic resistancePhei Er Saw, Qiang Liu, Ping-Pui Wong, et al.
Pageof 11